Srx Global Inc(SRXH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SRXH Srx Global Inc

Pre-Mkt 09-15 05:16:13 EDT

1.68

+0.09

+5.66%

盘前1.69

+0.01+0.60%

05:11 EDT

High1.70	Low1.56	Vol881.22K
Open1.58	D1 Closing1.59	Amplitude8.76%
Mkt Cap34.05M	Tradable Cap23.77M	Total Shares20.27M
T/O1.46M	T/O Rate6.23%	Tradable Shares14.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SRXH","market":"US","secType":"STK","nameCN":"Srx Global Inc","latestPrice":1.68,"timestamp":1789416000000,"preClose":1.59,"halted":0,"volume":881223,"hourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.68,"latestTime":"05:11 EDT","volume":347,"amount":586.1299838,"timestamp":1789463517958,"change":0.01,"changeRate":0.005952,"amplitude":0.011905},"delay":0,"changeRate":0.05660377358490557,"floatShares":14146500,"shares":20265400,"eps":-1.762,"marketStatus":"Pre-Mkt","change":0.09,"latestTime":"09-15 05:16:13 EDT","open":1.58,"high":1.6993,"low":1.56,"amount":1458373.7471667,"amplitude":0.08761,"askPrice":1.75,"askSize":100,"bidPrice":1.56,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-1.762,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"AMEX","adjPreClose":1.68,"preHourTrading":{"tag":"盘前","latestPrice":1.69,"preClose":1.68,"latestTime":"05:11 EDT","volume":347,"amount":586.1299838,"timestamp":1789463517958,"change":0.01,"changeRate":0.005952,"amplitude":0.011905},"postHourTrading":{"tag":"盘后","latestPrice":1.6606,"preClose":1.68,"latestTime":"19:30 EDT","volume":9982,"amount":16655.2384,"timestamp":1789428601486,"change":-0.0194,"changeRate":-0.011548,"amplitude":0.0175},"volumeRatio":1.6167455384794347},"requestUrl":"/m/hq/s/SRXH/wiki","defaultTab":"wiki","newsList":[{"id":"2666537842","title":"SRX Global Sells 3,579 Series C Preferred Shares in $2.83 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537842","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537842?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:01","pubTimestamp":1788980465,"startTime":"0","endTime":"0","summary":"SRX Global sells 3,579 Series C preferred shares in $2.83 million private placementSRX Global entered a private placement on Aug. 27, 2026, selling 3,579 shares of Series C convertible preferred stock","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6n6fJ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRXH","BK4212","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568874","title":"SRX Global Says ARMR-100 Fentanyl Vaccine Generates Immune Response in Phase 1/2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568874","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568874?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:17","pubTimestamp":1788437823,"startTime":"0","endTime":"0","summary":"SRX Global says ARMR-100 fentanyl vaccine generates immune response in Phase 1/2 trialSRX Global issued a shareholder update on ARMR Sciences’ ongoing Phase 1/2 trial of ARMR-100, a fentanyl-targeting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLz5jVP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2V16.EUR","BK4212","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","SG9999014021.USD","BK4585","LU2210150020.SGD","IE00BN0W2W23.USD","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014039.USD","SRXH","LU2095319765.USD","LU0314104364.USD","BK4112","IE00B3QW5Z07.USD","BK4128","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664743478","title":"Srx Global Provides Shareholder Update on Portfolio Company, Armr Sciences, a Clinical-Stage Biodefense Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2664743478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664743478?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:15","pubTimestamp":1788437700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA3BK5NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRXH","BK4212","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841988","title":"SRX Global Buys Senior Secured Debt in CERo Therapeutics Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841988?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:48","pubTimestamp":1788382101,"startTime":"0","endTime":"0","summary":"SRX Global buys senior secured debt in CERo Therapeutics HoldingsSRX Global bought senior secured debt in CERo Therapeutics Holdings to fund development of its engineered T-cell therapy program.Procee","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7ZD6Wn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4139","BK4212","CERO","SRXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070565","title":"SRX Global Buys Senior Secured Debt in CERo Therapeutics Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070565?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:30","pubTimestamp":1788175858,"startTime":"0","endTime":"0","summary":"SRX Global buys senior secured debt in CERo Therapeutics HoldingsSRX Global bought senior secured debt in CERo Therapeutics Holdings to provide additional capital for CERo’s clinical programs.CERo has","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLb7ZvSz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4139","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","LU2210150020.SGD","BCDF","SG9999014013.SGD","CERO","IE00BQXX3C00.GBP","LU0314104364.USD","BK4128","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4212","BK4588","IE00BQXX3F31.USD","LU2210149790.SGD","BK4585","IE00BN0W2W23.USD","NDAQ","SG9999014005.SGD","SRXH","IE00B64PRP62.GBP","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663907032","title":"Srx Global Acquires Senior Secured Debt in Cero Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2663907032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663907032?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:30","pubTimestamp":1788175800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA7HMYNN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4128","BK4212","BK4139","SRXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070340","title":"Srx Global - Investment Expected to Accelerate Cero Clinical Program Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070340?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:30","pubTimestamp":1788175800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA7HMYNN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRXH","BK4128","BK4212","BK4139","CERO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663151580","title":"SRX Global Sells 3,579 Series C Preferred Shares in Private Placement Valued at $2.86 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663151580","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663151580?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:03","pubTimestamp":1787951029,"startTime":"0","endTime":"0","summary":"SRX Global sells 3,579 Series C preferred shares in private placement valued at $2.86 millionSRX Global entered a private placement on Aug. 27, 2026, issuing 3,579 shares of Series C convertible prefe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL6bXHbx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4139","CERO","SRXH","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673791","title":"SRX Health Solutions Q3 Sales Rise on Halo Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673791","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673791?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:18","pubTimestamp":1786652326,"startTime":"0","endTime":"0","summary":"SRX Health Solutions Q3 sales rise on Halo strengthOverviewUS AI-enabled investment platform's fiscal Q3 sales rose 27% yr/yrAdjusted EBITDA loss for fiscal Q3 improved 35% yr/yr to $1.6 mlnCompany ap","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4166","SRXH","DFDV","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659516227","title":"SRX Global FY26 Q3 Net Loss from Continuing Operations Narrows 40% Year over Year to $4.1 Million; Net Sales Rise 27% to $3.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659516227","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659516227?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:13","pubTimestamp":1786651997,"startTime":"0","endTime":"0","summary":"SRX Global FY26 Q3 net loss from continuing operations narrows 40% year over year to $4.1 million; net sales rise 27% to $3.4 millionSRX Global posted fiscal Q3 net sales of USD 3.4 million, up 27% ye","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5nCqkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SRXH","BK4128","BK4112","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014021.USD","SG9999014005.SGD","NDAQ","BK4212","SG9999014039.USD","IE00BGHQF748.EUR","BCDF","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659118162","title":"SRX HealthSolutions Q3 EPS $(0.36) Up From $(44.51) YoY, Sales $3.392M Up From $2.673M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659118162","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659118162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:09","pubTimestamp":1786651746,"startTime":"0","endTime":"0","summary":"SRX HealthSolutions (AMEX:SRXH) reported quarterly losses of $(0.36) per share. This is a 99.19 percent increase over losses of $(44.51) per share from the same period last year.  The company reported $3.392 million in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61192670/srx-healthsolutions-q3-eps-0-36-44-51-yoy-sales-3-392m-2-673m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SRX HealthSolutions Q3 EPS $(0.36) Up From $(44.51) YoY, Sales $3.392M Up From $2.673M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRXH","BK4128","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659651162","title":"Press Release: SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659651162","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659651162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"-- Operating loss improved 63% year over year to $3.2 million. -- Net loss from continuing operations improved 40% year over year and 35%. -- Adjusted EBITDA loss improved 35% year over year to $1.6 million4. -- Ended the quarter with $36.7 million of cash, cash equivalents and. restricted cash, $65.2 million in current assets and $2.4 million of. aggregate) to shareholders of record on July 22, 2026; the Company has. treasury platform led by Eric M. Jackson, expanding the Company's. June. Halo delivered record Prime Day performance, including 13%. year-over-year growth in New-to-Brand customers and search cost-per-click. of $2.51, approximately 8% below the pet category benchmark.5\"The third quarter was transformational for SRX Global,\" commented Kent Cunningham, Chief Executive Officer. \"We completed the acquisition of EMJX, strengthened Halo's underlying operations and ended the quarter with a highly liquid balance sheet and approximately $62.9 million in NAV. Together, these accomp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","SRXH","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657631339","title":"SRX Global Schedules Fiscal Q3 2026 Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657631339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657631339?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:31","pubTimestamp":1786019490,"startTime":"0","endTime":"0","summary":"SRX Global schedules fiscal Q3 2026 results conference callSRX Global schedules its fiscal Q3 2026 results conference call for Aug. 13, 2026 at 4:30 p.m. ET.Webcast access will be available at https:/","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3rZw4f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2W23.USD","NDAQ","SRXH","LU2095319765.USD","SG9999014021.USD","IE00BKPKM429.USD","BCDF","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4588","BK4212","IE00BGHQF748.EUR","BK4585","BK4112","LU0314104364.USD","BK4128","SG9999014039.USD","LU2210149790.SGD","SG9999014005.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656530239","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2656530239","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656530239?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:07","pubTimestamp":1785841651,"startTime":"0","endTime":"0","summary":"Rain Enhancement Technologies  shares were up more than 98% pre-bell Tuesday, continuing from a 6.4% rise in the prior session.Elong Power  stock was 55% higher, recovering from a 40% loss in the previous session. The company said Monday it priced a registered offering of about 11.5 million units at $0.12 apiece for expected gross proceeds of $1.38 million.Ensysce Biosciences  shares were up 48% pre-bell, after a 11% increase at the prior close.Ameresco  stock was up more than 30% after the company overnight reported higher Q2 revenue.Vistagen Therapeutics  shares were 11% higher after SRX Global  said it acquired a stake in the late-stage clinical biopharmaceutical company.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENSC","VTGN","BK4007","SRXH","BK4539","RAIN","BK4139","BK4161","BK4128","ELPW","AMRC","BK4129","BK4096","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656531516","title":"SRX Global acquires stake in Vistagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2656531516","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656531516?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:10","pubTimestamp":1785834651,"startTime":"0","endTime":"0","summary":"SRX Global (SRXH) announced that it has acquired a stake in Vistagen (VTGN). The company said it views Vistagen shares as undervalued and welcomes ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/srx-global-acquires-stake-in-vistagen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/srx-global-acquires-stake-in-vistagen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRXH","BK4128","BK4212","BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656393375","title":"SRX Global Acquires Stake in Vistagen Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2656393375","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656393375?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:00","pubTimestamp":1785834025,"startTime":"0","endTime":"0","summary":"SRX Global acquires stake in Vistagen TherapeuticsSRX Global acquired a stake in Vistagen Therapeutics, taking a minority equity position in the Nasdaq-listed biotech.The investment targets Vistagen’s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL7YbB2C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2W23.USD","BK4585","BK4128","IE00BN0W2T93.GBP","BK4588","SG9999014013.SGD","IE00BGHQF748.EUR","SG9999014021.USD","BCDF","LU2095319765.USD","SG9999014039.USD","IE00BKPKM429.USD","SRXH","BK4139","IE00BN0W2V16.EUR","BK4212","SG9999014005.SGD","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","VTGN","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539338","title":"Srx Global Acquires Stake in Vistagen Therapeutics (Nasdaq: Vtgn)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656539338?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:00","pubTimestamp":1785834000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA1HJZX6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","BK4139","SRXH","VTGN","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379041","title":"Srx Global Portfolio Company Smartkem, Inc. (Nasdaq: Smtk) Announces Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379041?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:44","pubTimestamp":1785761092,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA14QFGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","BK4141","SMTK","SRXH","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655072678","title":"SRX Global Buys Shares in Jersey Mike’s IPO at USD 23 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2655072678","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655072678?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:05","pubTimestamp":1785434706,"startTime":"0","endTime":"0","summary":"SRX Global buys shares in Jersey Mike’s IPO at USD 23 per shareSRX Global acquired shares in Jersey Mike’s initial public offering.Jersey Mike’s IPO priced Class A common shares at USD 23 per share, i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLr9PsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014013.SGD","SG9999014039.USD","SRXH","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","BK4128","BK4212","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655807402","title":"Srx Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2655807402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655807402?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:04","pubTimestamp":1785434689,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2FC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","SRXH","BK4212"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.srxhealth.com","stockEarnings":[{"period":"1week","weight":0.1126},{"period":"1month","weight":-0.125},{"period":"3month","weight":-0.8526},{"period":"6month","weight":-0.7914},{"period":"1year","weight":-0.9085},{"period":"ytd","weight":-0.8773}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Better Choice Company Inc. operates as an animal health and wellness company. Its products portfolio includes naturally formulated kibble and canned dog and cat foods, freeze-dried raw dog foods and treats, vegan dog foods and treats, oral care products and supplements, as well as toppers, dental products, chews, and grooming products. The company sells its products under Halo Holistic and Halo Elevate brands. Better Choice Company Inc. primarily sells its products through its online portals, as well as through online retailers and pet specialty stores. It has operations in the United States, Canada, China, and Asia. The company was formerly known as Sports Endurance, Inc. and changed its name to Better Choice Company Inc. in March 2019. Better Choice Company Inc. was founded in 1986 and is based in Tampa, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.153592},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.064381},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.086428},{"month":4,"riseRate":0.375,"avgChangeRate":4.226231},{"month":5,"riseRate":0.375,"avgChangeRate":-0.079547},{"month":6,"riseRate":0.25,"avgChangeRate":-0.032386},{"month":7,"riseRate":0.25,"avgChangeRate":-0.26925},{"month":8,"riseRate":0.5,"avgChangeRate":-0.038716},{"month":9,"riseRate":0.25,"avgChangeRate":-0.195881},{"month":10,"riseRate":0.571429,"avgChangeRate":0.196923},{"month":11,"riseRate":0.571429,"avgChangeRate":0.064596},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.06138}],"exchange":"AMEX","name":"Srx Global Inc","nameEN":"Srx Global Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Srx Global Inc(SRXH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Srx Global Inc(SRXH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Srx Global Inc,SRXH,Srx Global Inc股票,Srx Global Inc股票老虎,Srx Global Inc股票老虎国际,Srx Global Inc行情,Srx Global Inc股票行情,Srx Global Inc股价,Srx Global Inc股市,Srx Global Inc股票价格,Srx Global Inc股票交易,Srx Global Inc股票购买,Srx Global Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Srx Global Inc(SRXH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Srx Global Inc(SRXH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction